⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Form 8-K
sec.gov
OGN
Form 8-K
sec.gov
OGN
Orogen Royalties Announces Permitting Update for Portal Construction at Ermitaño's Navidad Deposit
accessnewswire.com
AG
OGN
Are TBRG, OGN, MDV Obtaining Fair Deals for their Shareholders?
prnewswire.com
OGN
MDV
TBRG
Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN
businesswire.com
OGN
Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS ® (denosumab injection) and TUZEMTY ® (denosumab injection), Biosimilars to PROLIA and XGEVA
businesswire.com
OGN
Organon Canada et Henlius élargissent l’accès aux traitements à base de dénosumab avec le lancement de BILDYOS® (injection de dénosumab) et de TUZEMTY® (injection de dénosumab), des biosimilaires de PROLIA et de XGEVA
businesswire.com
OGN
Organon Canada et Henlius élargissent l’accès aux traitements à base de dénosumab avec le lancement de BILDYOS ® (injection de dénosumab) et de TUZEMTY ® (injection de dénosumab), des biosimilaires de PROLIA et de XGEVA
businesswire.com
OGN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
globenewswire.com
APGE
ROKU
TBRG
OGN
ABBV
FOXA
Organon Completes Agreement to License MIUDELLA ®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
businesswire.com
OGN